News: BIOC Biocept Inc. (BIOC Stock Report) manag
Post# of 63696
(Total Views: 256)
Posted On: 03/04/2020 2:38:47 PM
News: BIOC Biocept Inc. (BIOC Stock Report) managed to steady its course after consolidating from previous highs late last month. If you are just “tuning in,” Biocept broke out to highs of $0.789 on February 28. After hitting those highs, BIOC stock pulled back to around $0.40. What was a catalyst to this drop?
Take a look at the company’s newsfeed and you’ll see it announced a $9.2 million offering priced at $0.40 & planned to close by March 4. This is a necessary “evil” for public companies. In fact, most if not all pubco’s are public to utilize the markets to raise funds. In this case, “at the market” was not defined well.
That’s considering the stock traded near $0.80 one trading day prior. In any case, shares are now trading consistently above $0.40 and the company is lush with a few million in cash. In light of the closing date, this may have been a catalyst on its own to signal a positive for the market.
Penny Stocks To Watch: AIM ImmunoTech
penny stocks to watch AIM ImmunoTech (AIM)
AIM ImmunoTech (AIM Stock Report) is another one of the popular penny stocks to watch this year. It was caught up in the initial hype of coronavirus stocks. However, one of the key differences between AIM stock and others is that it actually has a treatment that can be applied to coronavirus. That’s according to the company, of course.
Its Ampligen product may provide similar effects against COVID-19 as it did on SARS. Additionally, the company signed a deal with ChinaGoAbroad to facilitate entry of the drug into China. The goal is to use it against early cases o COVID-19.
Read More
Best Penny Stocks To Buy Today? 1 Up 177% This Month
Best Non-Coronavirus Penny Stocks To Watch This Week?
Top Gold Penny Stocks To Watch For March 2020
AIM CEO Thomas K. Equals explained, “Ampligen achieved a 100% survival rate, as compared to 100% mortality in the untreated control animals, in SARS animal experiments after the outbreak in 2003. In these experiments, Ampligen was administered to mice prior to and shortly after infection. The Company believes that Ampligen may provide similarly effective prophylaxis against COVID-19, as both coronaviruses are extremely similar in key regulatory RNA sequences essential for coronaviral replication.”
Take a look at the company’s newsfeed and you’ll see it announced a $9.2 million offering priced at $0.40 & planned to close by March 4. This is a necessary “evil” for public companies. In fact, most if not all pubco’s are public to utilize the markets to raise funds. In this case, “at the market” was not defined well.
That’s considering the stock traded near $0.80 one trading day prior. In any case, shares are now trading consistently above $0.40 and the company is lush with a few million in cash. In light of the closing date, this may have been a catalyst on its own to signal a positive for the market.
Penny Stocks To Watch: AIM ImmunoTech
penny stocks to watch AIM ImmunoTech (AIM)
AIM ImmunoTech (AIM Stock Report) is another one of the popular penny stocks to watch this year. It was caught up in the initial hype of coronavirus stocks. However, one of the key differences between AIM stock and others is that it actually has a treatment that can be applied to coronavirus. That’s according to the company, of course.
Its Ampligen product may provide similar effects against COVID-19 as it did on SARS. Additionally, the company signed a deal with ChinaGoAbroad to facilitate entry of the drug into China. The goal is to use it against early cases o COVID-19.
Read More
Best Penny Stocks To Buy Today? 1 Up 177% This Month
Best Non-Coronavirus Penny Stocks To Watch This Week?
Top Gold Penny Stocks To Watch For March 2020
AIM CEO Thomas K. Equals explained, “Ampligen achieved a 100% survival rate, as compared to 100% mortality in the untreated control animals, in SARS animal experiments after the outbreak in 2003. In these experiments, Ampligen was administered to mice prior to and shortly after infection. The Company believes that Ampligen may provide similarly effective prophylaxis against COVID-19, as both coronaviruses are extremely similar in key regulatory RNA sequences essential for coronaviral replication.”
(0)
(0)
The majority of my post are the top 20% gainer! To decode them its (ticker ID, % Changed, Volume, Close price and Float) I typically put V,C&F as a prefix to that number and use K, M and B as a suffix (Kilo, Million & Billion) for volume and float. I may also use S for Support and R for Resistance.
I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.
I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.
Scroll down for more posts ▼